Back to Search Start Over

Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors.

Authors :
Paudel, Siddhi N.
Hutzen, Brian J.
Miller, Katherine E.
Garfinkle, Elizabeth A. R.
Chun-Yu Chen
Pin-Yi Wang
Glaspell, Andrea M.
Currier, Mark A.
Ringwalt, Emily M.
Boon, Louis
Mardis, Elaine R.
Cairo, Mitchell S.
Ratner, Nancy
Dodd, Rebecca D.
Cassady, Kevin A.
Cripe, Timothy P.
Source :
Frontiers in Immunology; 2024, p01-02, 2p
Publication Year :
2024

Abstract

This document is a corrigendum for an article titled "Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors." The corrigendum addresses an error in the legend for Figure 1, where the tumor models were mistakenly referred to as xenografts instead of syngeneic models. The corrected legend clarifies that the study used syngeneic tumor models. The authors apologize for the error and state that it does not affect the scientific conclusions of the article. [Extracted from the article]

Details

Language :
English
ISSN :
16643224
Database :
Complementary Index
Journal :
Frontiers in Immunology
Publication Type :
Academic Journal
Accession number :
178602172
Full Text :
https://doi.org/10.3389/fimmu.2024.1456897